Page last updated: 2024-08-21

quinazolines and Dermatitis, Contact, Phototoxic

quinazolines has been researched along with Dermatitis, Contact, Phototoxic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doan, HQ; Goldstein, J; Hu, MI; Patel, AB; Piha-Paul, SA; Subbiah, V1
Qiu, XY; Yin, Y; Zhang, B; Zhang, YH1
Brun, P; Dall'Acqua, S; Salvador, A; Vedaldi, D1
Burke, NS; Dassanayake, S; Mealey, KL1
Fine, HA; Kong, HH; Stern, JB; Turner, ML1
Guitart, J; Lacouture, ME; Lai, SE; Luu, M; Patel, J1

Reviews

1 review(s) available for quinazolines and Dermatitis, Contact, Phototoxic

ArticleYear
Vandetanib photoinduced cutaneous toxicities.
    Cutis, 2019, Volume: 103, Issue:5

    Topics: Aged; Antineoplastic Agents; Dermatitis, Phototoxic; Drug Eruptions; Female; Humans; Male; Middle Aged; Piperidines; Quinazolines

2019

Other Studies

5 other study(ies) available for quinazolines and Dermatitis, Contact, Phototoxic

ArticleYear
A rare cutaneous phototoxic rash after vandetanib therapy in a patient with thyroid cancer: A case report.
    Medicine, 2019, Volume: 98, Issue:31

    Topics: Adult; Antineoplastic Agents; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Piperidines; Quinazolines; Thyroid Neoplasms

2019
Vandetanib-induced phototoxicity in human keratinocytes NCTC-2544.
    Toxicology in vitro : an international journal published in association with BIBRA, 2014, Volume: 28, Issue:5

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Survival; Dermatitis, Phototoxic; DNA Damage; Humans; Lysosomes; Mice; Mitochondria; Oxidation-Reduction; Piperidines; Protein Kinase Inhibitors; Quinazolines; Serum Albumin, Bovine; Thiobarbituric Acid Reactive Substances; Ultraviolet Rays

2014
Tyrosine kinase inhibitors enhance ciprofloxacin-induced phototoxicity by inhibiting ABCG2.
    Oncology, 2014, Volume: 87, Issue:6

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Ciprofloxacin; Dermatitis, Phototoxic; Drug Synergism; Flow Cytometry; Gefitinib; Gene Expression Regulation; HEK293 Cells; Humans; Imatinib Mesylate; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk Factors

2014
Cutaneous pigmentation after photosensitivity induced by vandetanib therapy.
    Archives of dermatology, 2009, Volume: 145, Issue:8

    Topics: Aged; Antineoplastic Agents; Dermatitis, Phototoxic; Female; Humans; Hyperpigmentation; Middle Aged; Piperidines; Protein-Tyrosine Kinases; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Skin

2009
Photosensitive rash due to the epidermal growth factor receptor inhibitor erlotinib.
    Photodermatology, photoimmunology & photomedicine, 2007, Volume: 23, Issue:1

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dermatitis, Phototoxic; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines

2007